Towards Innovation in Healthcare: Beyond Pitching Day
Marking the Transition to the ‘’Test & Development’’ Phase
The Beyond Pitching Day, held on the 4th of February at the Novartis Cyprus premises, marked an important milestone in the programme, as teams concluded the Educational Phase and presented their healthcare business ideas to a distinguished jury committee.
The jury committee featured esteemed professionals from various industries, including Jevgenija Kirillova – CFO Novartis Cyprus & Malta, Andri Andreou – External Affairs Manager, Novartis Cyprus, Marilena Paraskeva – Head of the Funding Programmes Department, Research and Innovation Foundation, Petroula Gerasimou – Molecular Diagnostic Laboratory Supervisor, Karaiskakio Foundation, Michalis Strouthos – Co-Founder & CEO, Cocoon Creations & Crew, and George Pelekanos – Website Administrator, Marketing & CX, Bank of Cyprus.
After an inspiring round of pitches and valuable feedback from the jury committee, the teams have now advanced to the Test and Development Phase, where they will receive an initial funding to start building their Minimum Viable Product (MVP).
Beyond Pitching Day was a testament to the innovation, dedication, and entrepreneurial spirit of the participants. As teams enter the Test and Development Phase, they are one step closer to bringing their ideas to life. In this phase, with the support of Junior Achievement (JA) Cyprus, the focus will be on refining business models and developing prototypes.
The program is conducted with the sponsorship of Novartis Pharma Services Inc. Cyprus and the support of partner organizations: Cyprus Institute of Neurology and Genetics, Cocoon Creations, CYENS Centre of Excellence, Cyprus Federation of Patients’ Associations (CyFPA), Cyprus Oncology Society, Cyprus Seeds, Gravity Ventures, Idea Innovation Centre, Karaiskakio Foundation and Kinisis Ventures.
Junior Achievement Cyprus is member of the global non-profit organization JA Worldwide, specializing in education on entrepreneurship, financial literacy, and the job market. More information can be found at www.jacyprus.org.
Novartis AG is a Swiss multinational, innovative pharmaceutical company headquartered in Basel, Switzerland. Novartis Pharma Services Inc. Cyprus is the local representative and has been operating in the country since 2009. Our purpose is to reimagine medicine to improve and extend people’s lives. We use innovative science and technology to address some of society’s most challenging healthcare issues. We discover and develop breakthrough treatments and find new ways to deliver them to as many people as possible. In 2024, our medicines reached 296 million patients around the world. More information can be found at https://www.novartis.com/ or the local Facebook page https://www.facebook.com/NovartisCyprus
For inquiries or more information, please contact us at eleni.tovletian@jacyprus.org
